Automation index

How much of a Product owner’s job can AI already do?

A backlog and a user story write fast. Telling engineering no, and a customer yes, do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#175 / 643

Product owner

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Write stories, criteria and backlog. Estimate No public source provides a precise figure. This is our estimate.	22%	50%	+11
Maps, roadmaps and release notes. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Refine with engineering and design. Estimate No public source provides a precise figure. This is our estimate.	16%	18%	+2.9
Talk to users and stakeholders. Estimate No public source provides a precise figure. This is our estimate.	16%	15%	+2.4
Prioritise, cut scope and say no. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Accept the increment and own the value. Estimate No public source provides a precise figure. This is our estimate.	14%	16%	+2.2
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 643

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low